| Summary: | Objective: To study the effect of butyl phthalide on serum cytokines, soluble apoptosis
factors and antioxidant molecules in patients with vascular dementia. Methods: 86 patients
with vascular dementia admitted in our hospital between January 2014 and January 2016
were selected for retrospective study and divided into observation group and control group
(n=43) according to double-blind randomized control. Observation group received butyl
phthalide capsule (0.2 g/time, 3 times/d) treatment on the basis of conventional treatment,
control group received conventional treatment alone, and both lasted for 24 weeks. After 24
weeks of treatment, ELISA was used to determine serum levels of vascular repair factors
and soluble apoptosis factors of two groups of patients, and radioimmunoassay was used
to determine serum levels of antioxidant molecules. Results: After 24 weeks of treatment,
serum vascular repair factors heme oxygenase-1 (HO-1), angiogenin I (AngI) and vascular
endothelial growth factor (VEGF) levels of observation group were higher than those of
control group, matrix metalloproteinase-9 (MMP-9) level was lower than that of control group,
and differences between groups were statistically significant (P<0.05); serum soluble factorrelated
apoptosis (sFas) and soluble factor-related apoptosis ligand (sFasL) levels were lower
than those of control group (P<0.05); serum antioxidant molecules superoxide dismutase
(SOD), glutathione peroxidase (GSH-Px), total antioxidant capacity (TAC), catalase (CAT),
glutathione S-transferase (GST) and glutathione reductase (GR) levels were higher than those
of control group (P<0.05). Conclusions: Butyl phthalide can prompt vascular repair in patients
with vascular dementia, and also inhibit apoptosis process and balance the body’s oxidation/
antioxidation system function.
|
|---|
